share_log

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results

SEC announcement ·  May 9 07:07
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more